Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe

Two classes of antiviral drugs are licensed in Europe for treatment and prophylaxis of influenza; the M2 ion-channel blockers amantadine and rimantadine acting against type A influenza viruses only and the neuraminidase enzyme inhibitors zanamivir and oseltamivir acting against type A and type B inf...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pozo, F. (author)
Outros Autores: Bruno, L. (author), Rebelo-de-Andrade, H. (author), Vicent, E. (author), Rossyvaikis, A. (author), Broger, E. (author), Daniel, R. (author), Lankenby, A. (author), Meijer, A. (author)
Formato: article
Idioma:eng
Publicado em: 2015
Assuntos:
Influenza
Antiviral Drugs
Susceptibility Testing
Guidance
Resistência aos Antimicrobianos
Texto completo:http://hdl.handle.net/10400.18/2935
País:Portugal
Oai:oai:repositorio.insa.pt:10400.18/2935

Texto Completo

http://hdl.handle.net/10400.18/2935

Registos relacionados